BACKGROUND: Women with early-stage breast cancer face a multitude of decisions. The quality of a decision can be measured by the extent to which the treatment reflects what is most important to an informed patient. Reliable and valid measures of patients' knowledge and their goals and concerns related to breast cancer treatments are needed to assess the decision quality. OBJECTIVE: To identify a set of key facts and goals relevant to each of three breast cancer treatment decisions (surgery, reconstruction and adjuvant chemotherapy and hormone therapy) and to evaluate the validity of the methods used to identify them. METHODS: Candidate facts and goals were chosen based on evidence review and qualitative studies with breast cancer patients and providers. Cross-sectional surveys of patients and providers were conducted for each decision. The accuracy, importance and completeness of the items were examined. RESULTS: Thirty-eight facts (11-14 per decision) and 27 goals (8-10 per decision) were identified. An average of 17 patients and 21 providers responded to each survey. The sets of facts were accurate and complete for all three decisions. The sets of goals and concerns were important for surgery and reconstruction, but not chemotherapy/hormone therapy. Patients and providers disagreed about the relative importance of several key facts and goals. CONCLUSIONS: Overall, breast cancer patients and providers found the sets of facts and goals accurate, important and complete for three treatment decisions. Because patients' and providers' perspectives are different, it is vital that instrument development should include items reflecting both views.
BACKGROUND:Women with early-stage breast cancer face a multitude of decisions. The quality of a decision can be measured by the extent to which the treatment reflects what is most important to an informed patient. Reliable and valid measures of patients' knowledge and their goals and concerns related to breast cancer treatments are needed to assess the decision quality. OBJECTIVE: To identify a set of key facts and goals relevant to each of three breast cancer treatment decisions (surgery, reconstruction and adjuvant chemotherapy and hormone therapy) and to evaluate the validity of the methods used to identify them. METHODS: Candidate facts and goals were chosen based on evidence review and qualitative studies with breast cancerpatients and providers. Cross-sectional surveys of patients and providers were conducted for each decision. The accuracy, importance and completeness of the items were examined. RESULTS: Thirty-eight facts (11-14 per decision) and 27 goals (8-10 per decision) were identified. An average of 17 patients and 21 providers responded to each survey. The sets of facts were accurate and complete for all three decisions. The sets of goals and concerns were important for surgery and reconstruction, but not chemotherapy/hormone therapy. Patients and providers disagreed about the relative importance of several key facts and goals. CONCLUSIONS: Overall, breast cancerpatients and providers found the sets of facts and goals accurate, important and complete for three treatment decisions. Because patients' and providers' perspectives are different, it is vital that instrument development should include items reflecting both views.
Authors: P Ananian; G Houvenaeghel; C Protière; P Rouanet; S Arnaud; J P Moatti; A Tallet; A C Braud; C Julian-Reynier Journal: Ann Surg Oncol Date: 2004-07-12 Impact factor: 5.344
Authors: Timothy Whelan; Mark Levine; Andrew Willan; Amiram Gafni; Ken Sanders; Doug Mirsky; Shelley Chambers; Mary Ann O'Brien; Susan Reid; Sacha Dubois Journal: JAMA Date: 2004-07-28 Impact factor: 56.272
Authors: Timothy Whelan; Carol Sawka; Mark Levine; Amiram Gafni; Leonard Reyno; Andrew Willan; Jim Julian; Susan Dent; Hakam Abu-Zahra; Edmond Chouinard; Richard Tozer; Kathleen Pritchard; Ilona Bodendorfer Journal: J Natl Cancer Inst Date: 2003-04-16 Impact factor: 13.506
Authors: E Dale Collins; Caroline P Moore; Kate F Clay; Stephen A Kearing; Annette M O'Connor; Hilary A Llewellyn-Thomas; Richard J Barth; Karen R Sepucha Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Sarah T Hawley; Yun Li; Lawrence C An; Kenneth Resnicow; Nancy K Janz; Michael S Sabel; Kevin C Ward; Angela Fagerlin; Monica Morrow; Reshma Jagsi; Timothy P Hofer; Steven J Katz Journal: J Clin Oncol Date: 2018-01-24 Impact factor: 44.544
Authors: Clara N Lee; Yuchiao Chang; Nesochi Adimorah; Jeff K Belkora; Beverly Moy; Ann H Partridge; David W Ollila; Karen R Sepucha Journal: J Am Coll Surg Date: 2011-11-06 Impact factor: 6.113
Authors: Wess A Cohen; Tiffany N S Ballard; Jennifer B Hamill; Hyungjin M Kim; Xiaoxue Chen; Anne Klassen; Edwin G Wilkins; Andrea L Pusic Journal: Ann Plast Surg Date: 2016-08 Impact factor: 1.539
Authors: Clara Nan-Hi Lee; Peter Anthony Ubel; Allison M Deal; Lillian Burdick Blizard; Karen R Sepucha; David W Ollila; Michael Patrick Pignone Journal: Ann Surg Date: 2016-12 Impact factor: 12.969
Authors: Clara Nan-Hi Lee; Allison M Deal; Ruth Huh; Peter Anthony Ubel; Yuen-Jong Liu; Lillian Blizard; Caprice Hunt; Michael Patrick Pignone Journal: JAMA Surg Date: 2017-08-01 Impact factor: 14.766
Authors: Karen R Sepucha; Jeffrey K Belkora; Yuchiao Chang; Carol Cosenza; Carrie A Levin; Beverly Moy; Ann Partridge; Clara N Lee Journal: BMC Med Inform Decis Mak Date: 2012-06-08 Impact factor: 2.796
Authors: Clara Nan-Hi Lee; Michael Patrick Pignone; Allison M Deal; Lillian Blizard; Caprice Hunt; Ruth Huh; Yuen-Jong Liu; Peter Anthony Ubel Journal: JAMA Surg Date: 2018-04-18 Impact factor: 14.766